RNU6-323P

Across TCGA pan-cancer cohorts, RNU6-323P RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RNU6-323P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-323P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-323P expression acts as an unfavorable survival marker, although some lineages such as SKCM and LUAD show a favorable association.

KIRC, THCA, and UCEC are the cancer types where RNU6-323P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.520	0.714	<.001	133	view →
THCA	DFS	Median	All	0.909	0.958	.006	23	view →
UCEC	DFS	Median	All	0.568	0.690	.005	22	view →
MESO	OS	Median	All	0.458	0.615	.008	20	view →
KIRP	DFS	Tertile	IV	0.100	0.634	.003	18	view →
SKCM	OS	Median	II,III,IV	0.470	0.296	.003	17	view →
LUAD	DFS	Tertile	II,III,IV	0.751	0.523	.003	15	view →
KICH	DFS	Quartile	II,III,IV	0.563	0.935	.022	13	view →
DLBC	OS	Median	II,III,IV	1.000	0.312	.023	10	view →
BLCA	OS	Median	All	0.354	0.497	.017	9	view →
ESCA	DFS	Median	IV	0.213	0.626	.026	9	view →
READ	DFS	Tertile	IV	0.242	0.631	.011	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

RNU6-323P–KIRC (OS)

Open the KIRC breakdown →